z-logo
Premium
Neuron‐specific non‐classical release of prothymosin alpha: a novel neuroprotective damage‐associated molecular patterns
Author(s) -
Halder Sebok Kumar,
Matsunaga Hayato,
Ueda Hiroshi
Publication year - 2012
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2012.07897.x
Subject(s) - microglia , neuroprotection , ischemia , hippocampus , cerebral cortex , striatum , neuron , biology , pharmacology , microbiology and biotechnology , chemistry , neuroscience , medicine , immunology , inflammation , dopamine
Prothymosin alpha ( P ro T α), a nuclear protein devoid of signal sequence, has been shown to possess a number of cellular functions including cell survival. Most recently, we demonstrated that P ro T α is localized in the nuclei of neurons, while it is found in both nuclei and cytoplasm in the astrocytes and microglia of adult brain. However, the cell type‐specific non‐classical release of P ro T α under cerebral ischemia is yet unknown. In this study, we report that P ro T α is non‐classically released along with S100A13 from neurons in the hippocampus, striatum and somatosensory cortex at 3 h after cerebral ischemia, but amlexanox (an anti‐allergic compound) reversibly blocks this neuronal P ro T α release. We found that none of P ro T α is released from astrocytes and microglia under ischemic stress. Indeed, P ro T α intensity is increased gradually in astrocytes and microglia through 24 h after the cerebral ischemia. Interestingly, Z‐Val‐Ala‐Asp fluoromethyl ketone, a caspase 3 inhibitor, pre‐treatment induces P ro T α release from astrocytes in the ischemic brain, but this release is reversibly blocked by amlexanox. However, Z‐Val‐Ala‐Asp fluoromethyl ketone as well as amlexanox has no effect on P ro T α distribution in microglia upon cerebral ischemia. Taken together, these results suggest that only neurons have machineries to release P ro T α upon cerebral ischemic stress in vivo .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom